Organo Beheer

Beheer criteriumcontroles 1/4

De CEO Organo is Masayuki Yamada, benoemd in Jun2022, heeft een ambtstermijn van 2.42 jaar. bezit rechtstreeks 0.037% van de aandelen van het bedrijf, ter waarde ¥ 148.05M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.3 jaar en 2.4 jaar.

Belangrijke informatie

Masayuki Yamada

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.4yrs
Eigendom CEO	0.04%
Management gemiddelde ambtstermijn	3.3yrs
Gemiddelde ambtstermijn bestuur	2.4yrs

Recente managementupdates

Recent updates

Analysts Are Updating Their Organo Corporation (TSE:6368) Estimates After Its First-Quarter Results

Aug 02

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥53.00

Jul 25

Organo (TSE:6368) Has Announced A Dividend Of ¥53.00

Jul 11

What Organo Corporation's (TSE:6368) P/E Is Not Telling You

Jun 25

Is Organo (TSE:6368) A Risky Investment?

May 10

Returns On Capital Are Showing Encouraging Signs At Organo (TSE:6368)

Apr 25

Organo's (TSE:6368) Dividend Will Be ¥41.00

Mar 25

What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Mar 17

Organo Corporation's (TSE:6368) 28% Share Price Surge Not Quite Adding Up

Mar 02

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥41.00

Feb 27

CEO

Masayuki Yamada (65 yo)

2.4yrs

Tenure

Mr. Masayuki Yamada is President of Organo Corporation from June 2022 and has been its Executive Officer since July 2021. He was Senior Managing Director at Organo Corporation since July 2021 until June 20...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Masayuki Yamada	President	2.4yrs	geen gegevens	0.037% ¥ 148.1m
Yasutoshi Nakayama	MD, Managing Exec. Officer	no data	geen gegevens	0.071% ¥ 283.1m
Shin Asano	Managing Executive Officer	no data	geen gegevens	geen gegevens
Makoto Tomizawa	Managing Executive Officer	no data	geen gegevens	geen gegevens
Nobuyoshi Suda	MD, Executive Officer	no data	geen gegevens	0.058% ¥ 232.6m
Tetsushi Honda	MD, Executive Officer	no data	geen gegevens	0.052% ¥ 209.9m
Makoto Kukizaki	Managing Executive Officer	no data	geen gegevens	geen gegevens
Ken Shimada	Executive Officer	7.3yrs	geen gegevens	geen gegevens
Fusayoshi Akimoto	Executive Officer	no data	geen gegevens	geen gegevens
Koike Shojiro	Executive Officer	no data	geen gegevens	geen gegevens
Koh Yoshida	Executive Officer	3.3yrs	geen gegevens	geen gegevens

3.3yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 6368 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Masayuki Yamada	President	5.4yrs	geen gegevens	0.037% ¥ 148.1m
Yasutoshi Nakayama	MD, Managing Exec. Officer	6.4yrs	geen gegevens	0.071% ¥ 283.1m
Nobuyoshi Suda	MD, Executive Officer	5.4yrs	geen gegevens	0.058% ¥ 232.6m
Tetsushi Honda	MD, Executive Officer	3.3yrs	geen gegevens	0.052% ¥ 209.9m
Daisaku Abe	Independent Outside Director	1.4yrs	geen gegevens	geen gegevens
Morifumi Wada	Independent Outside Director	1.4yrs	geen gegevens	0.00022% ¥ 881.5k
Yoshihiro Tajitsu	Audit & Supervisory Board Member	1.4yrs	geen gegevens	0.0048% ¥ 19.2m
Hirohito Kodama	Outside Independent Audit & Supervisory Board Member	1.4yrs	geen gegevens	0.00022% ¥ 881.5k
Kenji Hirai	Independent Outside Director	5.4yrs	geen gegevens	0.019% ¥ 77.5m
Wataru Higuchi	Outside Independent Audit & Supervisory Board Member	5.4yrs	geen gegevens	geen gegevens
Nobuko Hanao	Independent Outside Director	1.4yrs	geen gegevens	0.00022% ¥ 881.5k
Naomi Kodama	Independent Outside Director	less than a year	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 6368 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.4 jaar), wat duidt op een nieuw bestuur.

Organo Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Organo Corporation, Annual General Meeting, Jun 27, 2024

Organo Corporation, Annual General Meeting, Jun 29, 2023

Less than half of directors are independent

Organo Corporation, Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 25%

New minor risk - Share price stability

Second quarter 2025 earnings: EPS exceeds analyst expectations

Organo (TSE:6368) Seems To Use Debt Quite Sensibly

What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Organo's (TSE:6368) Dividend Will Be ¥53.00

Organo Corporation to Report Q2, 2025 Results on Nov 01, 2024

Upcoming dividend of JP¥53.00 per share

Under The Bonnet, Organo's (TSE:6368) Returns Look Impressive

Organo's (TSE:6368) Dividend Will Be ¥53.00

Organo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025

Analysts Are Updating Their Organo Corporation (TSE:6368) Estimates After Its First-Quarter Results

First quarter 2025 earnings: EPS misses analyst expectations

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥53.00

Organo (TSE:6368) Has Announced A Dividend Of ¥53.00

Final dividend of JP¥53.00 announced

What Organo Corporation's (TSE:6368) P/E Is Not Telling You

Organo Corporation to Report Q1, 2025 Results on Jul 31, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

Organo Corporation, Annual General Meeting, Jun 27, 2024

Is Organo (TSE:6368) A Risky Investment?

Returns On Capital Are Showing Encouraging Signs At Organo (TSE:6368)

Price target increased by 20% to JP¥8,000

Organo's (TSE:6368) Dividend Will Be ¥41.00

Organo Corporation to Report Fiscal Year 2024 Results on May 13, 2024

Upcoming dividend of JP¥41.00 per share

What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Organo Corporation's (TSE:6368) 28% Share Price Surge Not Quite Adding Up

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥41.00

Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Organo Corporation to Report Q3, 2024 Results on Feb 02, 2024

Organo Corporation Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Organo Corporation Revises Dividend Forecasts for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2024

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Organo Corporation to Report Q2, 2024 Results on Nov 01, 2023

Upcoming dividend of JP¥33.00 per share at 1.7% yield

New minor risk - Share price stability

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Organo Corporation to Report Q1, 2024 Results on Aug 01, 2023

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 11% to JP¥4,100

Organo Corporation, Annual General Meeting, Jun 29, 2023

Upcoming dividend of JP¥29.00 per share at 1.7% yield

Organo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Price target increased by 8.6% to JP¥3,800

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Organo Corporation to Report Q3, 2023 Results on Feb 01, 2023

Price target increased to JP¥3,500

Less than half of directors are independent

Organo Corporation Announces Dividend for the Second Quarter Ended September 30, 2022, Payable on December 5, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023

Second quarter 2023 earnings: Revenues in line with analyst expectations

Organo Corporation Revises Consolidated Earnings Guidance for the Six Months Ended September 30, 2022 and for the Fiscal Year Ending March 31, 2023

Consensus revenue estimates increase by 13%

Investor sentiment improved over the past week

Organo Corporation to Report Q2, 2023 Results on Oct 31, 2022

Upcoming dividend of JP¥80.00 per share

Organo Corporation Provides Dividend Guidance for the Second Quarter Ending September 30, 2022

First quarter 2023 earnings released: EPS: JP¥131 (vs JP¥71.27 in 1Q 2022)

Organo Corporation to Report Q1, 2023 Results on Aug 01, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Organo Corporation Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2023

Organo Corporation, Annual General Meeting, Jun 29, 2022

Price target increased to JP¥10,200

Less than half of directors are independent

Organo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥72.00 per share

Investor sentiment improved over the past week